NeoGenomics
NEO
15.97
-0.54
-3.24%
NeoGenomics
US · NEO
#2660 by market cap
Listed 1970
15.97
-0.54
-3.24%
Live - 5344 symbols - heartbeat 153s ago
· 2026-10-08 08:39
Pre-market
15.71
-1.66%
After-hours
15.97
0.00%
Overnight
16.02
+0.31%
- Market cap
- 2.05B
- P/E (TTM)i
- -40.95
- P/Bi
- 2.61
- EPSi
- -0.84
- Div yieldi
- 0.00%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on NEO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.48, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +10.11% YoY
Margins
- Gross margin
- 43.21%
- Operating margin
- -12.12%
- Net margin
- -14.85%
Key ratios & quality
- Enterprise valuei
- 2.24B
- Altman Z-Scorei
- 2.48
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 276.74M | 408.83M | 444.45M | 484.33M | 509.73M | 591.64M | 660.57M | 727.33M |
| Gross profit | 127.27M | 196.84M | 185.89M | 187.06M | 187.90M | 244.60M | 290.10M | 314.29M |
| Selling & admin expenses | 114.22M | 175.34M | 191.66M | 283.94M | 277.91M | 279.96M | 310.49M | 331.65M |
| Research & development | 3.00M | 8.49M | 8.23M | 21.87M | 30.33M | 27.31M | 31.16M | 37.08M |
| Operating profit | 10.04M | 13.01M | -13.99M | -118.75M | -153.11M | -96.65M | -85.45M | -88.13M |
| Pretax profit | 3.82M | 3.65M | -14.06M | -15.08M | -159.34M | -97.10M | -80.68M | -110.27M |
| Tax | 1.18M | -4.36M | -18.23M | -6.73M | -15.09M | -9.13M | -1.95M | -2.24M |
| Net profit | 2.64M | 8.01M | 4.17M | -8.35M | -144.25M | -87.97M | -78.73M | -108.03M |
| Basic EPS | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 |
| Diluted EPS | 0.07 | 0.08 | 0.04 | -0.07 | -1.16 | -0.70 | -0.62 | -0.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 168.04M | 181.33M | 187.80M | 190.17M | 186.67M | 201.66M |
| Gross profit | 73.25M | 77.26M | 80.45M | 83.34M | 80.86M | 91.88M |
| Selling & admin expenses | 90.89M | 95.82M | 91.68M | 53.26M | 89.57M | 90.89M |
| Research & development | 10.18M | 9.02M | 8.69M | 9.18M | 9.53M | 10.76M |
| Operating profit | -27.83M | -27.59M | -19.93M | -12.79M | -18.24M | -9.77M |
| Pretax profit | -25.66M | -45.82M | -26.39M | -12.41M | -17.58M | 1.83M |
| Tax | 266.00K | -724.00K | 740.00K | -2.53M | -472.00K | -412.00K |
| Net profit | -25.92M | -45.09M | -27.13M | -9.88M | -17.11M | 2.24M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.20 | -0.35 | -0.21 | -0.08 | -0.13 | 0.02 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 103.67M | 290.74M | 448.73M | 681.51M | 605.29M | 596.81M | 596.02M | 376.29M |
| Cash & ST investments | 9.81M | 173.02M | 296.26M | 515.39M | 437.99M | 415.20M | 386.84M | 159.62M |
| Inventory | 8.65M | 14.41M | 29.53M | 23.40M | 24.28M | 24.16M | 26.75M | 28.57M |
| Total assets | 505.02M | 709.51M | 988.33M | 1.87B | 1.74B | 1.68B | 1.64B | 1.36B |
| Total current liabilities | 60.93M | 63.90M | 73.18M | 87.23M | 89.93M | 96.30M | 301.24M | 88.30M |
| Short-term debt | 14.17M | 13.81M | 7.81M | 8.02M | 6.65M | 5.61M | 204.16M | 4.78M |
| Long-term debt | 92.88M | 91.83M | 168.12M | 532.48M | 535.32M | 538.20M | 340.34M | 341.86M |
| Total liabilities | 184,572,000.00 | 202,098,000.00 | 294,037,000.00 | 761,501,000.00 | 742,011,000.00 | 739,692,000.00 | 735,699,000.00 | 523,268,000.00 |
| Total equity | 320.44M | 507.41M | 694.29M | 1.11B | 998.02M | 941.54M | 902.34M | 836.56M |
| Retained earnings | -19.36M | -11.36M | -7.19M | -14.84M | -159.09M | -247.06M | -325.78M | -433.81M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 573.93M | 392.55M | 382.47M | 376.29M | 373.68M | 381.48M |
| Cash & ST investments | 358.08M | 163.69M | 164.12M | 159.62M | 146.14M | 145.54M |
| Inventory | 29.77M | 34.17M | 28.46M | 28.57M | 29.84M | 27.14M |
| Total assets | 1.60B | 1.39B | 1.37B | 1.36B | 1.35B | 1.35B |
| Total current liabilities | 279.70M | 100.12M | 97.87M | 88.30M | 84.59M | 105.88M |
| Short-term debt | 204.21M | 4.05M | 4.51M | 4.78M | 4.83M | 5.43M |
| Long-term debt | 340.71M | 341.10M | 341.48M | 341.86M | 342.24M | 374.24M |
| Total liabilities | 713,161,000.00 | 539,910,000.00 | 536,490,000.00 | 523,268,000.00 | 517,771,000.00 | 566,511,000.00 |
| Total equity | 888.27M | 854.04M | 838.29M | 836.56M | 828.76M | 785.73M |
| Retained earnings | -351.70M | -396.80M | -423.93M | -433.81M | -450.91M | -448.67M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 44.79M | 23.37M | 1.46M | -26.72M | -65.99M | -1.95M | 7.02M | 5.23M |
| Depreciation & amortization | 21.73M | 30.27M | 35.72M | 53.35M | 69.43M | 72.58M | 72.55M | 67.82M |
| Free cash flow | 30.48M | 3.34M | -27.64M | -90.87M | -96.88M | -30.71M | -34.04M | -21.78M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 144.09M | 171.98M | 147.60M | 423.21M | 12.59M | 4.62M | 4.65M | 962.00K |
| Ending cash balance | 9.81M | 173.02M | 250.63M | 316.83M | 263.18M | 342.49M | 367.01M | 159.62M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -25.33M | 20.33M | 8.88M | 1.34M | -8.14M | 19.96M |
| Depreciation & amortization | 17.73M | 17.26M | 16.44M | 16.40M | 16.41M | 16.21M |
| Free cash flow | -29.83M | 14.01M | 570.00K | -6.53M | -13.14M | 11.74M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 949.00K | -949.00K | 531.00K | 431.00K | -338.00K | -24.66M |
| Ending cash balance | 346.19M | 154.72M | 164.12M | 159.62M | 146.14M | 145.54M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 2.47 | 1.93 | 0.69 | -0.93 | -13.70 | -9.07 | -8.54 | -12.42 |
| ROA %i | 1.44 | 1.32 | 0.49 | -0.58 | -7.99 | -5.14 | -4.74 | -7.21 |
| ROIC %i | 2.92 | 2.00 | 1.20 | -0.35 | -8.58 | -6.14 | -5.90 | -8.22 |
| 5-year avg ROE %i | -3.95 | -4.12 | -3.59 | -0.47 | -1.90 | -4.21 | -6.31 | -8.93 |
| EBIT margin %i | 3.63 | 1.80 | -1.58 | -2.06 | -30.96 | -15.24 | -11.21 | -14.64 |
| FCF / sales %i | 11.01 | 0.82 | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.70 | 4.55 | 6.13 | 7.81 | 6.73 | 6.20 | 1.98 | 4.26 |
| Quick ratioi | 1.42 | 4.18 | 5.51 | 7.19 | 6.20 | 5.67 | 1.78 | 3.61 |
| Debt / assetsi | 22.24 | 18.73 | 22.18 | 32.77 | 35.11 | 36.38 | 36.95 | 30.11 |
| LT debt / equityi | 30.62 | 23.46 | 30.45 | 54.57 | 60.55 | 64.37 | 44.46 | 48.37 |
| Interest coveragei | 1.61 | 1.98 | -1.00 | -1.97 | -104.80 | -13.06 | -11.19 | -28.38 |
| Revenue CAGR (3Y) %i | 40.49 | 20.82 | 22.76 | 20.51 | 7.63 | 10.01 | 10.90 | 12.58 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 93.94 | -37.89 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -8.57 | -11.76 | -12.99 | -12.42 | -11.56 | -6.33 |
| ROA %i | -4.79 | -6.85 | -7.52 | -7.21 | -6.73 | -3.78 |
| ROIC %i | -5.83 | -8.11 | -8.72 | -8.22 | -7.54 | -4.38 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -10.72 | -14.46 | -15.40 | -14.64 | -13.33 | -6.78 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.05 | 3.92 | 3.91 | 4.26 | 4.42 | 3.60 |
| Quick ratioi | 1.82 | 3.16 | 3.26 | 3.61 | 3.71 | 3.03 |
| Debt / assetsi | 37.77 | 29.54 | 29.85 | 30.11 | 30.34 | 33.16 |
| LT debt / equityi | 45.10 | 47.74 | 48.41 | 48.37 | 48.71 | 56.37 |
| Interest coveragei | -11.01 | -17.13 | -22.86 | -28.38 | -36.39 | -20.13 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:39:56 · For reference only, not investment advice and not tailored to your situation.